Market Samachar

Aprea Therapeutics (APRE) Details Patent Portfolio Amidst Unprofitable Status and Insider Buying

Read full article on gurufocus.com ↗

Market Samachar is a news aggregator. This article was originally published by gurufocus.com. Tap the button above to read the full story on their site.

• INDIAN US stocks today: US stocks open subdued ahead of Warsh's speech Markets-Economic Times
• INDIAN Sebi bars Trafiksol ITS, promoters from securities market for one year Share Market Today
• INDIAN Prestige launches new residential project 'Palm Court' in North Chennai Share Market Today
• INDIAN Aditya Birla Capital allots 1.41 lakh equity shares under ESOP Share Market Today
• INDIAN Centre announces ₹30,000 crore govt securities buyback via auction Share Market Today
• INDIAN Bond yields hit over two-month high; rupee gains on RBI intervention Share Market Today
• INDIAN Coforge expands partnership with Pega Share Market Today
• INDIAN Pulse of the Street: Foreign buying fails to break August stalemate in Indian equities mint - markets

More from Market Samachar

• Is 'out of control' US tipping culture spreading overseas? BBC News
• Traders are skeptical of Iran timeline for Strait of Hormuz reopening Finance
• Stocks making the biggest moves after hours: Snowflake, Marvell Technology, Agilent Technologies & more Finance
• Boeing CEO says company met requirements to increase 737 Max production to 47 jets per month Business News
• Abercrombie shares jump 12% on earnings beat even as Iran conflict hits sales Business News